Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sophie Billioti de Gage"'
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100486- (2022)
Summary: Background: Oral HIV pre-exposure prophylaxis (PrEP) has been available and fully reimbursed for people at high risk of sexually acquired HIV infection in France since January 2016. Its dissemination has been widely promoted to reduce HIV in
Externí odkaz:
https://doaj.org/article/5707e94cd292491fafacdcfa39cc3c37
Publikováno v:
The Lancet Public Health. 7:e529-e536
Pre-exposure prophylaxis (PrEP) has shown high efficacy in clinical trials, but few observational studies have confirmed its effectiveness when prescribed in real life to users with diverse profiles. This study aimed to assess real-world PrEP effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c578e960e4731a282161778797c1f6
https://doi.org/10.1016/s2468-2667(22)00106-2
https://doi.org/10.1016/s2468-2667(22)00106-2
Publikováno v:
Therapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d9cfd2de4ed7f4d65d66fdf635ee31a
https://doi.org/10.1016/j.therap.2023.02.010
https://doi.org/10.1016/j.therap.2023.02.010
Autor:
E. Laurent, Leslie Grammatico-Guillon, Guillaume Gras, Marc-Florent Tassi, Karl Stefic, Florence Lot, Sophie Billioti de Gage, Francis Barin
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:3002-3008
Background Clinical trials have demonstrated that oral pre-exposure prophylaxis (PrEP) has high efficacy in preventing HIV transmission. In many countries, HIV testing is recommended prior to PrEP initiation, 1 month after and quarterly thereafter. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92bcde03125fe769d9bebb8bcbc7081f
https://doi.org/10.1093/jac/dkab263
https://doi.org/10.1093/jac/dkab263
Publikováno v:
Ophthalmology and therapy. 11(2)
The risk of thromboembolic events or death in patients treated with intravitreal anti-vascular endothelial growth factor (IVT anti-VEGF) is poorly described on a large scale and by molecule. This study aimed to assess the risk of myocardial infarctio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d99dcdead24b21ff554345585a1987
https://pubmed.ncbi.nlm.nih.gov/35072917
https://pubmed.ncbi.nlm.nih.gov/35072917
Autor:
Marc-Florent Tassi, Emeline Laurent, Guillaume Gras, Florence Lot, Francis Barin, Sophie Billioti de Gage, Karl Stefic, Leslie Grammatico-Guillon
Publikováno v:
Santé Publique. 34:8e-8e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::448e3772c01733de3a38454a96e4b1ad
https://doi.org/10.3917/spub.220.0008e
https://doi.org/10.3917/spub.220.0008e
Introduction: Several studies have highlighted an increased risk of dementia in benzodiazepine users. As dementia incidence and benzodiazepine use are both high, particularly in the elderly, even a moderate increase in this risk would induce a tremen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c600f624a95031da10fee967d2d40bca
Autor:
Sophie, Billioti de Gage, Cédric, Collin, Thien, Le-Tri, Antoine, Pariente, Bernard, Bégaud, Hélène, Verdoux, Rosemary, Dray-Spira, Mahmoud, Zureik
Publikováno v:
CNS Drugs
Background Hepatotoxicity may be a concern when prescribing antidepressants. Nevertheless, this risk remains poorly understood for serotonin and noradrenaline reuptake inhibitors (SNRIs: venlafaxine, milnacipran, duloxetine) and ‘other antidepressa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a4a6b813fcaeafa3ab6a2dea32aa34a4
https://pubmed.ncbi.nlm.nih.gov/29959758
https://pubmed.ncbi.nlm.nih.gov/29959758
Publikováno v:
CNS drugs. 30(1)
The short-term effects of benzodiazepines on memory are well established and are suspected in the long term. Eleven studies have been published so far concerning benzodiazepine use and the risk of dementia disorders; nine of these studies concluded t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99cf3ec1aa81a6d8dda8cd5ef821618b
https://pubmed.ncbi.nlm.nih.gov/26715389
https://pubmed.ncbi.nlm.nih.gov/26715389
Publikováno v:
BMJ. 345:e7993-e7993
Coyle-Gilchrist and colleagues and Bocti and colleagues are directly or indirectly concerned with the possible non-causal nature of the association we found between benzodiazepines and dementia.1 2 3 We emphasise that we never concluded that this ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff9f953894e4d0c8d3aa2b6cdd317a7b
https://doi.org/10.1136/bmj.e7993
https://doi.org/10.1136/bmj.e7993